COVID-19 Webinars

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

By May 7, 2020April 22nd, 2021No Comments

JDD Multimedia

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

Join your dermatology colleagues and thought leaders as we examine the hidden impact of COVID-19 on dermatologists and providers, including new and small private practices, emotional wellbeing and the evolving priorities placed on providers during the global coronavirus pandemic. Panelists will discuss their first-hand, personal experience living with COVID-19 and ways it has impacted their physical and emotional health, practice and personal life.
Discussion and guidance will be given on simple steps you can take in the wellness sphere, crisis management and return to practice concepts for both large and small dermatology practices.

Moderators

  • Richard G. Fried, MD, PhD (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)

Panelists

  • Evan Rieder, MD (Board Certified Dermatologist & Psychiatrist, NYU Langone Health)
  • Paul Jarrod Frank, MD (Chief Medical Officer & Founder, PFRANKMD)
  • Melissa Kanchanapoomi Levin, MD (Founder, Entière Dermatology)

You May Also Like

Journal of Drugs in Dermatology JDD Article about Rapid Clearance of Lichen Planus With Topical TapinarofFeatured ArticlesLatest NewsMedical DermRapid Clearance of Lichen Planus With Topical Tapinarof
March 31, 2026

Rapid Clearance of Lichen Planus With Topical Tapinarof

Topical tapinarof associated with rapid resolution of shin lichen planus in a treatment resistant patient This is a must-read case report in JDD. The report describes a 70-year-old woman with…
Journal of Drugs in Dermatology JDD Article about Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia AreataAlopeciaFeatured ArticlesLatest NewsEfficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
March 30, 2026

Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata

A practical review of efficacy, safety, and real world considerations for advanced practice providers This is a must-read JDD article on JAK inhibitors for alopecia areata. The review summarizes current…
Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Aesthetics Is Changing. Here’s What We’re Seeing?AestheticsAlopeciaFeatured ArticlesHairJDD Re:ViewLatest NewsJDD Re:View With Dr. Beer
March 26, 2026

JDD Re:View With Dr. Beer

Hair Disorders and Treatments   Hair treatments have proliferated in the past several years. While prior treatment options were limited to topical minoxidil and oral finasteride for androgenetic alopecia (AGA),…

Leave a Reply